IL6 and COVID-19: In their meta-analysis, Hegyi et al. reported similarly elevated levels of pro-inflammatory mediators—IL-6, IL-8, and IL-10—in patients with both COVID-19 and AP, accompanied by inflammatory cell migration to sites of infection/inflammation and activation of coagulation pathways [88,89].